Ingevity Third-Quarter Profit Rises To $51.1 Million Even As Road Markings Sale Cuts Sales 8%
The specialty materials maker narrowed its full-year adjusted EBITDA range to $385 million to $395 million, keeping the prior midpoint.
Ingevity, which makes activated carbon, pavement additives and specialty polymers, said Wednesday that third-quarter net income from continuing operations rose to $51.1 million, or $1.46 per diluted share, from $40.8 million, or $1.10, a year earlier. Net sales fell 8% to $305.1 million after the April 15, 2026 sale of its Road Markings product line.
Margins widen as sales shrink
Excluding Road Markings, sales rose 2%. Adjusted earnings from continuing operations were $56.7 million, or $1.63 per share, against $48.3 million, or $1.31, a year earlier.
Adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) slipped $2.4 million to $108.0 million, yet its margin widened 230 basis points, or 2.3 percentage points, to 35.4%. The company credited favorable pricing and product mix and strong operating performance in Performance Materials, partly offset by higher input and logistics costs in Pavement Technologies and Advanced Polymer Technologies.
Ingevity bought back about $39 million of stock in the quarter at a weighted average $71.45 per share, bringing repurchases for the first nine months of 2026 to about $125 million. About $172 million of authorization remains.
Pavement is the weak spot
Pavement Technologies sales fell 24% to $106.0 million, mainly from the Road Markings divestiture. Segment EBITDA dropped $7.3 million to $19.6 million, hit by lower volumes, retained costs from the sale and higher input and logistics costs. Persistently higher asphalt costs, driven by crude oil inflation, are raising project costs for customers and limiting demand, the company said.
Performance Materials, the automotive emissions and filtration carbon business, held sales near flat at $154.1 million and segment EBITDA at $83.4 million. Advanced Polymer Technologies sales rose 18% to $45.0 million on higher pricing, including a surcharge, and segment EBITDA rose $0.7 million to $11.7 million.
Guidance tightens; polymers sale slips
Ingevity narrowed its full-year adjusted EBITDA outlook to $385 million to $395 million, maintaining the prior midpoint. It expects net sales of about $1.1 billion and adjusted EPS of $5.25 to $5.45, and free cash flow of $220 million to $230 million, excluding a $113.2 million litigation settlement payment made in the second quarter.
CEO Dave Li said the company continues to advance the sale of Advanced Polymer Technologies, but "the timing of an announced agreement may extend into early 2027." Net leverage held at 2.5 times, down from 2.7 times a year earlier.
Ingevity hosts a webcast Thursday at 10:00 a.m. Eastern to discuss the results.
Sources
- 8-K Filing — Ingevity Corp (NGVT) — SEC EDGAR
- Exhibit ex99109302026.htm — Ingevity Corp 8-K exhibit — SEC EDGAR
- Ingevity reports third quarter 2026 financial results — businesswire.com